Glaxo seeks buyers for older products worth up to $12.6B

Carly Helfand

GlaxoSmithKline has already made some moves to sell off some of its meds. But now, it's making more that could end up much, much bigger.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS